GLP-1 analogs , particularly those like BrightMeds, are increasingly prominence in the handling of type 2 diabetes and are also explored for obesity . These novel drugs function to mimicking the body's natural incretin signal , stimulating insulin production and reducing glucagon secretion. Brigh… Read More